Trademark: VYRALYM-M 2090434
Word
VYRALYM-M
ID
2090434
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
22 May 2020
Registration Date
22 May 2020
Renewal Date
22 May 2030
Owner(s)
Service
KINGS PATENT & TRADE MARKS ATTORNEYS PTY LTD
Goods and Services:
Class 5:
Biological preparations and products for medical and pharmaceutical purposes; culture media for medical or veterinary use; cultures of cell media for medical or veterinary use; cell growth media for growing cells for medical or clinical use; cells for medical or clinical use; pharmaceutical and veterinary products, preparations and substances; pharmaceutical products, preparations and substances for the treatment of a variety of human and animal diseases and disorders, including cancer, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, skeletal, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer; pharmaceutical products for treating respiratory diseases; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; therapeutic pharmaceuticals for the treatment of a variety of human and animal diseases and disorders, including cancer, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, skeletal, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; and cell therapy products for the treatment of a variety of human and animal diseases and disorders, including cancer, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, skeletal, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Biological preparations and products for medical and pharmaceutical purposes; culture media for medical or veterinary use; cultures of cell media for medical or veterinary use; cell growth media for growing cells for medical or clinical use; cells for medical or clinical use; pharmaceutical and veterinary products, preparations and substances; pharmaceutical products, preparations and substances for the treatment of a variety of human and animal diseases and disorders, including cancer, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, skeletal, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer; pharmaceutical products for treating respiratory diseases; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; therapeutic pharmaceuticals for the treatment of a variety of human and animal diseases and disorders, including cancer, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, skeletal, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; and cell therapy products for the treatment of a variety of human and animal diseases and disorders, including cancer, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, skeletal, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders